UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
______________________
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of report (Date of earliest event reported):
October 30, 2019
____________________________
ChineseInvestors.com, Inc.
(Exact name of registrant as specified in its charter)
____________________________
Indiana | 000-54207 | 35-2089868 |
(State of Organization) | (Commission File Number) | (I.R.S. Employer Identification Number) |
227 W. Valley Blvd. #208A, San Gabriel, CA | 91776 | |
(Address of principal executive offices) | (Zip Code) |
(626) 589-2468
(Registrant’s telephone number, including area code)
Check appropriate box below if the Form 8-K filing is intended to simultaneously satisfying the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title of each class | Trading Symbol(s) | Name of each exchange on which registered |
N/A | N/A | N/A |
☐ Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
Item 8.01 Other Events
The Company on October 30, 2019 issued a press release in which it announced that its subsidiary CBD Biotech, Inc., an exempted company with limited liability incorporated in the Cayman Islands (“CBD Biotech) will attend the "2019 China Industrial Cannabis Investment Seminar" on October 31, 2019 in Shanghai, China and the "2019 China Industrial Cannabis CBD Industry International Conference" on November 23-24, 2019, in Haerbing, China.
Item 9.01 Financial Statements and Exhibits
Exhibit Number | Description |
99.1 | Press Release dated October 30, 2019 |
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
Date: October 30, 2019
ChineseInvestors.com, Inc.
By: /s/ Wei Wang
Name: Wei Wang
Title: Chief Executive Officer
Exhibit 99.1
ChineseInvestors.com, Inc.’s Subsidiary CBD Biotech, Inc. to Attend Industrial Cannabis Conferences in China
San Gabriel, CA, (October 30, 2019) - ChineseInvestors.com, Inc. (OTCQB:CIIX) (“CIIX” or “the Company”), an established financial news and investment portal and a leading industrial hemp retailer for the Chinese-speaking community, today announced that its subsidiary CBD Biotech, Inc., an exempted company with limited liability incorporated in the Cayman Islands (“CBD Biotech) will attend the "2019 China Industrial Cannabis Investment Seminar" on October 31, 2019 in Shanghai, China and the "2019 China Industrial Cannabis CBD Industry International Conference" on November 23-24, 2019, in Haerbing, China.
These conferences are attended by companies and executives in China who are active in the industrial hemp market, like CBD Biotech, or have plans to enter the market in the near future, foreign industrial hemp companies, and institutional investors, secondary market institutional investors, and other high net worth investors interested in the industry.
CBD Biotech executives will be available at each of the upcoming conferences to provide information and education on its industrial hemp-infused skincare and cosmetic products, its hemp wine, and to discuss its strategic plans for future development. Slated to launch two new industrial hemp products soon, CBD Biotech will also feature its new products at these conferences.
Although the industrial hemp skincare and cosmetics industry is still in the early stages of development in China, as a first mover in this market, CBD Biotech has already laid the foundation to capitalize on this growing industry. It is legal in China to add industrial hemp/CBD extract to cosmetics, creating potential market of nearly 1.4 billion people for hemp-infused/CBD skincare and cosmetics.
About ChineseInvestors.com
Founded in 1999, ChineseInvestors.com endeavors to be an innovative company providing: (a) real-time market commentary, analysis, and educational related services in Chinese language character sets (traditional and simplified); (b) advertising and public relation related support services; and (c) retail, online and direct sales of hemp-based products and other health related products.
For more information, visit ChineseInvestors.com.
Subscribe and watch our video commentaries: https://www.youtube.com/user/Chinesefncom Follow us on Twitter for real-time Company updates: https://twitter.com/ChineseFNEnglsh Like us on Facebook to receive live feeds: https://www.facebook.com/Chinesefncom; https://www.facebook.com/Chineseinvestors.com.english
Add us on WeChat: Chinesefn or download iPhone iOS App: Chinesefn
Forward-looking Statements
This press release contains “forward-looking statements.” Such statements may be preceded by the words “intends,” “may,” “will,” “plans,” “expects,” “anticipates,” “projects,” “predicts,” “estimates,” “aims,” “believes,” “hopes,” “potential” or similar words. Forward-looking statements are not guarantees of future performance, are based on certain assumptions and are subject to various known and unknown risks and uncertainties, many of which are beyond the Company’s control, and cannot be predicted or quantified and consequently, actual results may differ materially from those expressed or implied by such forward-looking statements. Such risks and uncertainties include, without limitation, risks and uncertainties associated with (i) our inability to manufacture our products and product candidates on a commercial scale on our own, or in collaboration with third parties; (ii) difficulties in obtaining financing on commercially reasonable terms; (iii) changes in the size and nature of our competition; (iv) loss of one or more key executives or scientists; and (v) difficulties in securing regulatory approval to market our products and product candidates. More detailed information about the Company and the risk factors that may affect the realization of forward-looking statements is set forth in the Company’s filings with the Securities and Exchange Commission (SEC), including the Company’s Annual Report on Form 10-K and its Quarterly Reports on Form 10-Q. Investors and security holders are urged to read these documents free of charge on the SEC’s website at http://www.sec.gov. The Company assumes no obligation to publicly update or revise its forward-looking statements as a result of new information, future events or otherwise.
Contact:
ChineseInvestors.com
227 W. Valley Blvd., #208 A
San Gabriel, CA 91776
Investor Relations:
Alan Klitenic
+1-214-636-2548
PR@chinesefn.com
Corporate Communications:
NetworkWire (NNW)
New York, New York
www.NetworkNewsWire.com
+1-212-418-1217 Office
Editor@NetworkWire.com